Washington Post
Editorial
August 26, 2010
This week, a D.C. federal trial judge put a temporary halt to federally funded research on embryonic stem cells, concluding that current law prohibits the use of such money for work in which an embryo is damaged or destroyed. The decision is unnecessarily disruptive, creating uncertainty about the future of one of the most promising lines of research in recent memory. It also points out the need for Congress to clarify the rules that govern this scientifically important and morally delicate endeavor.
More
